Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

84307 Assay of somatostatin

Pathology & Lab

Also known as: somatostatin, somatostatin level, SRIF

Quantitative assay of serum somatostatin concentration, measuring this inhibitory neuroendocrine hormone.

In Plain Language

hormone regulation test

Clinical Context

Elevated in somatostatinomas and pancreatic neuroendocrine tumors; suppresses growth hormone, thyroid hormone, and insulin secretion.

RVU Information

CPT 84307 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.

Billing & Documentation

Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.

How This Code Compares

This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.

Specialties

EndocrinologyOncologyClinical Chemistry

Frequently Asked Questions

What is CPT code 84307?

CPT 84307 (Assay of somatostatin) is a Pathology & Lab code. Quantitative assay of serum somatostatin concentration, measuring this inhibitory neuroendocrine hormone.

Who uses CPT code 84307?

CPT 84307 is used by Endocrinology, Oncology, Clinical Chemistry. Elevated in somatostatinomas and pancreatic neuroendocrine tumors; suppresses growth hormone, thyroid hormone, and insulin secretion.

When is CPT 84307 used?

Elevated in somatostatinomas and pancreatic neuroendocrine tumors; suppresses growth hormone, thyroid hormone, and insulin secretion.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and benchmark against national data — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.